HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ben A C Dijkmans Selected Research

Org 37663

2/2010The selective estrogen receptor alpha agonist Org 37663 induces estrogenic effects but lacks antirheumatic activity: a phase IIa trial investigating efficacy and safety of Org 37663 in postmenopausal female rheumatoid arthritis patients receiving stable background methotrexate or sulfasalazine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ben A C Dijkmans Research Topics

Disease

62Rheumatoid Arthritis
06/2012 - 01/2002
13Arthritis (Polyarthritis)
04/2012 - 10/2002
11Inflammation (Inflammations)
04/2016 - 10/2002
7Ankylosing Spondylitis
04/2016 - 07/2003
5Osteoporosis
10/2011 - 08/2006
5Necrosis
02/2011 - 01/2002
4Synovitis
04/2012 - 07/2003
3Pain (Aches)
10/2013 - 02/2002
3Arthralgia (Joint Pain)
01/2012 - 03/2010
3Cardiovascular Diseases (Cardiovascular Disease)
08/2011 - 01/2006
3Heart Failure
07/2010 - 01/2002
3Rheumatic Diseases (Rheumatism)
10/2008 - 08/2006
3Neoplasms (Cancer)
10/2007 - 10/2004
2Multiple Myeloma
04/2012 - 09/2008
2Psoriatic Arthritis
09/2010 - 10/2002
2Autoimmune Diseases (Autoimmune Disease)
09/2010 - 08/2008
2Breast Neoplasms (Breast Cancer)
03/2009 - 02/2003
2Atherosclerosis
08/2008 - 01/2006
2Juvenile Arthritis (Juvenile Idiopathic Arthritis)
11/2007 - 02/2003
2Ulcer
10/2007 - 04/2004
2Infections
07/2006 - 01/2006
2Bone Resorption
09/2004 - 08/2004
1Insulin Resistance
03/2012
1Pulmonary Arterial Hypertension
04/2011
1Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary)
04/2011
1Systemic Scleroderma (Systemic Sclerosis)
04/2011
1Familial Primary Pulmonary Hypertension
04/2011
1Left Ventricular Dysfunction
07/2010
1Joint Diseases (Joint Disease)
07/2010
1Fatigue
06/2010

Drug/Important Bio-Agent (IBA)

13Methotrexate (Mexate)FDA LinkGeneric
02/2010 - 02/2002
11Adalimumab (Humira)FDA Link
04/2012 - 07/2006
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2016 - 01/2002
9Antirheumatic Agents (DMARD)IBA
04/2012 - 01/2002
8Anti-Citrullinated Protein AntibodiesIBA
01/2012 - 10/2002
7C-Reactive ProteinIBA
04/2016 - 07/2003
7AntibodiesIBA
10/2008 - 10/2002
6Pharmaceutical PreparationsIBA
06/2012 - 02/2006
6Infliximab (Remicade)FDA Link
02/2011 - 02/2005
6Immunoglobulin M (IgM)IBA
01/2011 - 10/2002
6Rheumatoid FactorIBA
01/2011 - 10/2002
6Sulfasalazine (Azulfidine)FDA LinkGeneric
02/2010 - 02/2002
4Tumor Necrosis Factor InhibitorsIBA
04/2015 - 01/2005
4GlucocorticoidsIBA
03/2012 - 08/2006
4Biomarkers (Surrogate Marker)IBA
01/2012 - 08/2004
4AutoantibodiesIBA
03/2010 - 02/2004
4cyclic citrullinated peptideIBA
03/2008 - 10/2002
3Etanercept (Enbrel)FDA Link
04/2016 - 01/2010
3Member 1 Subfamily B ATP Binding Cassette TransporterIBA
04/2012 - 02/2003
3Prednisolone (Predate)FDA LinkGeneric
03/2012 - 02/2002
3Diphosphonates (Bisphosphonates)IBA
10/2011 - 09/2004
3Proteins (Proteins, Gene)FDA Link
03/2009 - 02/2003
3multidrug resistance-associated protein 1IBA
03/2009 - 02/2003
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
02/2009 - 01/2002
3Folic Acid (Vitamin M)FDA LinkGeneric
01/2009 - 02/2003
2amsonic acid (DAS)IBA
06/2012 - 10/2007
2Interferon Type IIBA
04/2012 - 06/2011
2Rituximab (Mabthera)FDA Link
04/2012 - 06/2011
2Bortezomib (Velcade)FDA Link
04/2012 - 09/2008
2Proteasome InhibitorsIBA
04/2012 - 09/2008
2acetyl 4-aminosalicylic acidIBA
01/2012 - 11/2009
2LipidsIBA
12/2011 - 02/2005
2EpitopesIBA
11/2011 - 07/2010
2Monoclonal AntibodiesIBA
04/2011 - 07/2006
2CytokinesIBA
02/2011 - 03/2010
2Peptides (Polypeptides)IBA
01/2011 - 03/2008
2Pamidronate (Aredia)FDA LinkGeneric
07/2009 - 09/2004
2Prednisone (Sone)FDA LinkGeneric
05/2009 - 08/2006
2Leflunomide (Arava)FDA LinkGeneric
03/2009 - 01/2002
2alfacalcidolIBA
05/2007 - 08/2006
2Alendronate (Alendronate Sodium)FDA LinkGeneric
05/2007 - 08/2006
2Biological ProductsIBA
01/2006 - 01/2005
2ametantrone (HAQ)IBA
09/2003 - 02/2002
1PK 11195 (PK11195)IBA
04/2012
1carfilzomibIBA
04/2012
1Multidrug Resistance-Associated ProteinsIBA
04/2012
1Adenosine Triphosphate (ATP)IBA
04/2012
1Glucose (Dextrose)FDA LinkGeneric
03/2012
1AutoantigensIBA
11/2011
1ErbB Receptors (EGF Receptor)IBA
04/2011
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
04/2011
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2011
1recombinant human tumor necrosis factor-binding protein-1IBA
09/2010
1AdiponectinIBA
09/2010
1pro-brain natriuretic peptide (1-76)IBA
07/2010
1Interleukin-10 (Interleukin 10)IBA
07/2010
1HLA-DQA1 antigen (HLA DQA1)IBA
07/2010
1Genetic Markers (Genetic Marker)IBA
07/2010
1Brain Natriuretic Peptide (Natrecor)FDA Link
07/2010
1Messenger RNA (mRNA)IBA
06/2010
1Insulin-Like PeptidesIBA
06/2010
1InterferonsIBA
03/2010
1ChemokinesIBA
03/2010
1Estrogens (Estrogen)FDA Link
02/2010
1Estrogen Receptor alphaIBA
02/2010
1Org 37663IBA
02/2010

Therapy/Procedure

24Therapeutics
04/2015 - 02/2002
2Resistance Training
06/2005 - 04/2004
2Physical Therapy Modalities (Physical Therapy Technique)
04/2004 - 09/2003
1Retreatment
05/2011